Exelixis (EXEL)
NASDAQ:EXEL
Holding EXEL?
Track your performance easily

Exelixis (EXEL) Stock Investors

2,790 Followers
Based on 757,103 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold EXEL
On average, investors allocate 3.53% of their portfolios to EXEL
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 757,103 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding EXEL

2.6%
Last 7
Days
4.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding EXEL, out of 757,103 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

EXEL Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
1.90%
$27.60
Increased
3.81%
$26.38
Opened
4.63%
$27.60
Increased
0.30%
$22.82
Increased
3.86%
$18.08
Based on the activity of 14,465 investors who made their portfolios public
The table shows changes in EXEL in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

EXEL Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Bristol-Myers Squibb
3.44%
-1.33%
-2.60%
100.34B
Healthcare
Block
4.21%
-1.17%
-2.73%
41.45B
Technology
DraftKings
5.58%
-1.48%
+0.87%
34.22B
Consumer Cyclical
Trade Desk
4.84%
-1.57%
-1.99%
51.77B
Technology
Merck & Company
3.78%
-0.86%
+1.11%
299.84B
Healthcare
RTX
4.25%
-1.35%
-0.74%
157.94B
Industrials
Applied Materials
4.32%
+0.15%
+5.13%
155.47B
Technology
GE Aerospace
5.34%
+1.00%
+4.32%
195.53B
Industrials
CVS Health
4.01%
-0.71%
-1.96%
72.75B
Healthcare
Enphase Energy
5.04%
-1.63%
-4.99%
16.05B
Technology
Based on the activity of 757,103 active portfolios
Open your Smart Portfolio

EXEL Investor Analysis

EXEL investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.7%
of EXEL holders
are under 35
Average Segment Performance
Average P/E Ratio20.16
Beta8.32
Dividend Yield3.50%
EXEL investors between 35–55

Between 35–55

3.4%
Last 30 days
Holdings Change
50.5%
of EXEL holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.25
Beta13.76
Dividend Yield3.65%
EXEL investors over 55

Over 55

16.1%
Last 30 days
Holdings Change
37.8%
of EXEL holders
are over 55
Average Segment Performance
Average P/E Ratio20.06
Beta4.95
Dividend Yield3.36%
Overview of age group and performance of EXEL stock investors
See who invests in EXEL according to age group and performance.

FAQ

How many retail Investors hold EXEL?
<0.1% of TipRanks' retail investors hold EXEL in their portfolios.
    What is EXEL Investor Sentiment?
    EXEL’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of EXEL in the last 7 days?
      ▲ 2.6% of TipRanks' retail investors changed their holding of EXEL in the last 7 days.
        What percentage of retail investors changed their holding of EXEL in the last 30 days?
        ▲ 4.6% of TipRanks' retail investors changed their holding of EXEL in the last 30 days.
          What is the average age of retail investors who hold EXEL?
          The average age of EXEL Holders is between 35–55.
            What other stocks have EXEL investors also bought?
            EXEL Investors also bought BMY, SQ, DKNG, TTD, MRK, RTX, AMAT, GE, CVS, ENPH.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CPRXCatalyst Pharma
              AVDLAvadel Pharmaceuticals
              GERNGeron
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis